Innovive, LLC Appoints Jamie S. Blose, Pharm.D, MBA, JD as Chief Executive Officer ...

GSK inks agreement to acquire CMG1A46 from Chimagen Biosciences to expand immunology pipeline: London, UK Thursday, October 31, 2024, 10:00 Hrs [IST] GSK plc and Chimagen Bioscien ...

GSK (GSK) plc and Chimagen Biosciences, a privately held biotechnology company, announced an agreement for GSK to acquire ...

UK pharma major GSK is to buy CMG1A46, a clinical-stage dual CD19 and CD20-targeted T cell-engager (TCE), from privately-held ...

Cerebras Inference is providing a new compute foundation for the next era of AI innovation." From global pharmaceutical giants like GlaxoSmithKline (GSK), to pioneering startups like Audivi, Tavus, ...

This October, Grab is celebrating its 10th anniversary in Vietnam. Alejandro Osorio, managing director of Grab Vietnam, speaks to VIR's Linh Le about the key milestones achieved over the last decade ...

The update on the GSK-partnered prospect sent Wave’s share price up 63% to almost $14 despite coinciding with news that Takeda has axed a deal for another asset. The ongoing phase 1b/2a study is ...

GSK says it owns seven patents that “provide the foundation” for Moderna’s messenger RNA vaccine portfolio, and is now suing the biotechnology company for infringement. At issue is the work of a team ...

GSK is also seeking damages to compensate for the alleged infringement as well as a “compulsory ongoing licensing fee” for the claimed technologies. “Moderna has reaped billions of dollars in revenue ...